Investors
Information Disclosure
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 20222022.04.08
-
VOLUNTARY ANNOUNCEMENT – APPLICATION FOR CLINICAL TRIAL OF CATEGORY I NEW DRUG “TQC2938” INJECTION2022.04.08
-
NEXT DAY DISCLOSURE RETURN2022.04.08
-
VOLUNTARY ANNOUNCEMENT INNOVATIVE DRUG “TQ-B3525” WAS INCLUDED IN THE LIST OF BREAKTHROUGH THERAPY DRUGS BY CDE2022.04.08